Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS)
Cervical Cancer, Human Papillomavirus Infection
About this trial
This is an interventional screening trial for Cervical Cancer focused on measuring Screening, Human Papillomavirus Infection, Self-Testing
Eligibility Criteria
Inclusion Criteria:
- no history of hysterectomy or cervical cancer
- no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
- patient of Harris Health System in Harris County (Houston), Texas
- have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
- be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months
Exclusion Criteria:
- no valid telephone contact information
- unable to communicate in English or Spanish
- currently pregnant
- history of cervical dysplasia in the past 3.5 years
Sites / Locations
- Harris Health System
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Telephone Recall
Mailed HPV Self-Sampling Kit
Mailed HPV Self-Sampling Kit + Patient Navigation
Participants receive a scripted telephone recall from a trained patient navigator on behalf of Harris Health System.
Participants receive a scripted telephone recall from a patient navigator on behalf of Harris Health System and receive a mailed HPV self-sampling kit with a pre-paid return envelope.
Participants receive a scripted telephone recall and mailed self-sampling kit with a pre-paid return envelope. Within 3-5 days of the kit's mail-out, participants will receive a telephone call from a patient navigator to provide one-on-one education.